Comera Life Sciences Performance
| CMRADelisted Stock | USD 0.66 0.01 1.54% |
The firm shows a Beta (market volatility) of -1.02, which signifies a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Comera Life are expected to decrease slowly. On the other hand, during market turmoil, Comera Life is expected to outperform it slightly. Comera Life Sciences right now shows a risk of 0.0%. Please confirm Comera Life Sciences treynor ratio, accumulation distribution, price action indicator, as well as the relationship between the potential upside and day median price , to decide if Comera Life Sciences will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Comera Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Comera Life is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 6.6 M |
Comera |
Comera Life Relative Risk vs. Return Landscape
If you would invest 66.00 in Comera Life Sciences on September 3, 2024 and sell it today you would earn a total of 0.00 from holding Comera Life Sciences or generate 0.0% return on investment over 90 days. Comera Life Sciences is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Comera, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Comera Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Comera Life's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Comera Life Sciences, and traders can use it to determine the average amount a Comera Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CMRA |
Based on monthly moving average Comera Life is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Comera Life by adding Comera Life to a well-diversified portfolio.
Comera Life Fundamentals Growth
Comera Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Comera Life, and Comera Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Comera Pink Sheet performance.
| Return On Equity | -16.29 | |||
| Return On Asset | -1.19 | |||
| Operating Margin | (15.82) % | |||
| Current Valuation | 9.96 M | |||
| Shares Outstanding | 30.74 M | |||
| Price To Sales | 43.28 X | |||
| Revenue | 633.1 K | |||
| EBITDA | (13.33 M) | |||
| Cash And Equivalents | 4.94 M | |||
| Cash Per Share | 0.26 X | |||
| Total Debt | 775.05 K | |||
| Debt To Equity | 0.16 % | |||
| Book Value Per Share | (0.14) X | |||
| Cash Flow From Operations | (9.77 M) | |||
| Earnings Per Share | (0.22) X | |||
| Total Asset | 3.73 M | |||
| Retained Earnings | (34.9 M) | |||
About Comera Life Performance
By analyzing Comera Life's fundamental ratios, stakeholders can gain valuable insights into Comera Life's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Comera Life has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Comera Life has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts. Comera Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people.Things to note about Comera Life Sciences performance evaluation
Checking the ongoing alerts about Comera Life for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Comera Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Comera Life Sciences is not yet fully synchronised with the market data | |
| Comera Life Sciences has some characteristics of a very speculative penny stock | |
| Comera Life Sciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 633.1 K. Net Loss for the year was (18 M) with profit before overhead, payroll, taxes, and interest of 422.71 K. | |
| Comera Life Sciences currently holds about 4.94 M in cash with (9.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.26. | |
| Roughly 51.0% of the company shares are held by company insiders |
- Analyzing Comera Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Comera Life's stock is overvalued or undervalued compared to its peers.
- Examining Comera Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Comera Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Comera Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Comera Life's pink sheet. These opinions can provide insight into Comera Life's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Comera Pink Sheet
If you are still planning to invest in Comera Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Comera Life's history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |